Dcn Dx Acquires Microbiological Testing Products Company Biomed Diagnostics
04/25/22, 6:14 PM
Industry
science and engineering
data and analytics
health care
DCN Dx, a global leader in the end-to-end development, manufacture, and commercialization of point-of-use tests, today announced it has completed its acquisition of Biomed Diagnostics, Inc., a microbiological testing products company based in White City, Oregon.
Company Info
Company info
CN Dx is a global leader in the end-to-end development, manufacture, and commercialization of point-of-use tests. From its headquarters in Carlsbad, California, DCN Dx's cross-functional team of scientists and engineers develop and integrate all aspects of assays into reliable systems for point-of-use applications that enable users to monitor sample quality, identify pathogens, and facilitate the delivery of treatments. DCN Dx partners with industry leaders to develop point-of-use tests, train users in diagnostic development, and carry out clinical research for medical point-of-care testing, veterinary diagnostics, soil and water testing, bioprocessing, food safety, force protection, and more.
To learn more about DCN Dx's products and services, click here.
MEDIA CONTACT:
John L. Tonkinson, Ph.D.Chief Strategy Officer, DCN DxMain: (760) 804-3886 Mobile: (860) 977-4012 334866@email4pr.com
SOURCE DCN Dx